4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000146
EVP, Finance & CFO sold 225,220 shares at an average $72.43 ($16,313,676)
- EVP, Finance & CFO acquired 174,999 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
HOUGEN ELIZABETH L · EVP, Finance & CFO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +60,299 | $60.89 | $3,671,606 | 193,180 | D |
| 2026-03-16 | Exercise or conversion : show line 2 in the form 10b5-1 | +61,041 | $56.78 | $3,465,908 | 254,221 | D |
| 2026-03-16 | Exercise or conversion : show line 3 in the form 10b5-1 | +33,118 | $32.60 | $1,079,647 | 287,339 | D |
| 2026-03-16 | Exercise or conversion : show line 4 in the form 10b5-1 | +20,541 | $37.58 | $771,931 | 307,880 | D |
| 2026-03-16 | Sale : show line 5 in the form 10b5-1 | −205,608 | $72.38 | $14,882,113 | 102,272 | D |
| 2026-03-16 | Sale : show line 6 in the form 10b5-1 | −9,440 | $72.77 | $686,902 | 92,832 | D |
| 2026-03-17 | Sale : show line 7 in the form 10b5-1 | −10,172 | $73.21 | $744,662 | 82,660 | D |
| Open-market sales · 225,220 sh · avg $72.43 · $16,313,676 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-16 | Exercise or conversion : show line 8 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −33,118 | 0 | D |
| 2026-03-16 | Exercise or conversion : show line 9 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −20,541 | 5,405 | D |
| 2026-03-16 | Exercise or conversion : show line 10 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −61,041 | 0 | D |
| 2026-03-16 | Exercise or conversion : show line 11 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −60,299 | 0 | D |
Loading xslF345X06/edgardoc.xml…